Clarke, William A.

Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

Shrock, E., Fujimura, E., Kula, T., Timms, R. T., Lee, I.-H., Leng, Y., Robinson, M. L., Sie, B. M., Li, M. Z., Chen, Y., et al. (2020) · Science

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 678

An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples

Green, T. C., Park, J. N., Gilbert, M., McKenzie, M., Struth, E., Lucas, R., Clarke, W., & Sherman, S. G. (2020) · International Journal of Drug Policy

Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment

Cited by 211

Bedside glucose monitoring-is it safe? A new, regulatory-compliant risk assessment evaluation protocol in critically ill patient care settings

DuBois, J. A., Slingerland, R. J., Fokkert, M., Roman, A., Tran, N. K., Clarke, W., Sartori, D. A., Palmieri, T. L., Malic, A., Lyon, M. E., et al. (2017) · Critical Care Medicine

Hyperglycemia and glycemic control in critically ill and hospitalized patientsClinical Laboratory Practices and Quality Control

Cited by 59

A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry

Füzéry, A. K., Breaud, A. R., Emezienna, N., Schools, S., & Clarke, W. A. (2013) · Clinica Chimica Acta

Analytical Methods in PharmaceuticalsForensic Toxicology and Drug Analysis

Cited by 45

Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples

Park, J. N., Sherman, S. G., Sigmund, V., Breaud, A., Martin, K., & Clarke, W. A. (2022) · Drug and Alcohol Dependence

Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment

Cited by 43